In the landscape of restorative dentistry, the transition from removable prosthetics like dentures and bridges to permanent, ...
The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...
A study conducted by the Maccabident Research Institute found that ongoing national security tensions led to significant changes in the dental and skeletal development of children and teens.
Population aging is reshaping the landscape of respiratory disease, with COPD, idiopathic pulmonary fibrosis, bronchiectasis, ...
Each Olympic cycle, athletes and support staff chase the latest cutting-edge knowledge in pursuit of Gold. In the Winter ...
Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives January 28, 2026 4:00 PM ...
Pulmonary alveolar proteinosis (PAP) is a rare respiratory disease that affects somewhere between 4 and 40 people per million worldwide. The condition causes substances such as fats and proteins to ...
In recent years, significant advancements have been made in understanding how oral flora impacts not only bone health but also the complex interplay between ...
Invisible particles in the air are not just irritating our lungs, they are quietly rewiring the immune system that is ...
The European Medicines Agency has granted orphan drug status to LTI-03, an inhaled therapy being developed for people with IPF.
Discover how a gingivectomy treats gum disease and improves aesthetics. Learn about the procedure, pain levels, and costs ...